Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lars Fruergaard Jorgensen
Pharma
Novo reports mixed sales on GLP-1 stalwarts Ozempic, Wegovy
After disappointing earnings from Lilly last week, Novo Nordisk’s report on the performance of its GLP-1s Ozempic and Wegovy is more of a mixed bag.
Fraiser Kansteiner
Nov 6, 2024 2:34pm
Novo CEO agrees to discuss potential GLP-1 price cuts with PBMs
Sep 24, 2024 5:03pm
After subpoena threat, Novo CEO Jorgensen will testify at Senate
Jun 17, 2024 11:07am
Novo Nordisk grilled by Sanders over steep GLP-1 pricing
Apr 25, 2024 2:58pm
Novo Nordisk's CEO pockets a cool 13% raise in 2023
Feb 7, 2024 11:02am
JPM24: In obesity field, Novo is 'just getting going,' CEO says
Jan 10, 2024 11:45am
